Carol Routledge

Dr Carol Routledge is the Director of Research at Alzheimer’s Research UK where she currently drives the research agenda. Carol has moved to ARUK from the Dementia Discovery Fund, where she was a Venture Partner with a key focus on identifying and developing novel disease-modifying mechanisms for the treatment of all types of dementia, sourcing opportunities from academic research groups and small companies. She has had a successful career with a number of UK and US based major pharmaceutical and biotechnology companies with a focus on drug acquisition and leadership of translational medicine strategies for many NCEs and biologics across a number of therapeutic areas, with a focus on neuroscience. A combination of preclinical and clinical experience gives her the advantage of being able to apply a strong scientific rationale and innovative experimental approaches to clinical development. Carol has a PhD in Neuropharmacology from Queens Medical School in Nottingham